Notch genes encode a highly conserved family of transmembrane receptors that are involved in various developmental programs and cell fate decisions ([@bib2]). The broad range of processes that require Notch signaling is reflected by the variety of human diseases that result from mutations in components of the Notch signaling pathway ([@bib22]; [@bib27]). The mammalian genome encodes for 4 Notch receptors (Notch1--4) that can be activated by binding of ligands that belong to the Serrate-like (Jagged1 and Jagged2) or Delta-like (DLL1, DLL3, and DLL4) families ([@bib24]). Although the biological relevance of all these possible ligand--receptor interactions is still being elucidated, it is clear that they have a critical role in regulating normal developmental processes ([@bib4]). Ligand--receptor interactions lead to two sequential proteolytic cleavages of the Notch receptor and these are mediated by a metallo-protease and a multiprotein complex with γ-secretase activity, respectively. After cleavage, the active form of Notch (intracellular Notch \[ICN\]) migrates to the nucleus to activate transcription of downstream target genes, such as *Hes1*, *Nrarp*, and *Deltex1*.

Notch signaling is of critical importance during T cell development ([@bib32]; [@bib51]). In adult life, T lymphocytes are generated in the thymus after colonization by bone marrow--derived hematopoietic progenitor cells (HPCs). In humans, uncommitted CD34^+^CD1a^−^ thymocytes gradually commit to the T cell fate under the influence of the thymic microenvironment. This results in the induction of CD1a expression and the initiation of T cell receptor gene rearrangements at the TCR-δ, -γ, and -β loci ([@bib10]). While in frame, TCR-δ and -γ rearrangements will induce the generation of CD3^+^ γδ T cells, and a functional TCR-β chain will pair with the surrogate pre--TCR-α chain to form the pre-TCR complex that drives massive proliferation and differentiation toward CD4^+^CD8^+^ double-positive (DP) cells, a process called β-selection ([@bib38]). At the DP stage, TCR-α rearrangements are initiated to replace the pre-TCR complex with a fully functional TCR-αβ chain, and this allows the cells to undergo positive and negative selection, thereby generating immune-competent, non--self-reactive CD4^+^ and CD8^+^ single-positive αβ-lineage T cells ([@bib5]; [@bib30]).

In the mouse, induction of T cell development in HPCs is critically dependent on the Notch1--DLL4 interaction in the thymus ([@bib31]; [@bib47]; [@bib19]; [@bib23]). In the absence of either one of these proteins, thymus colonizing HPCs mainly adopt a B cell fate instead of differentiation along the T cell lineage. As a result of this early alteration in lineage choice, it is still unclear if differential Notch receptor--ligand interactions are involved in intrathymic cell fate decisions within the T-lineage pathway. This is of critical importance because it is well established that differences in Notch signal strength can influence TCR-αβ and -γδ T cell development ([@bib8]; [@bib14]; [@bib42]), but it is unclear how this is regulated in vivo. Given our recent finding that different Notch ligands induce differences in Notch signal strength when activating the Notch1 receptor, and our observation that different Notch ligands and receptors are expressed in the human postnatal thymus ([@bib42], [@bib43]), we examined which ligand--receptor interactions are involved in mediating human TCR-αβ and -γδ T cell development. Our findings illustrate that Notch ligands differentially affect both developmental processes through preferential interactions with specific Notch receptors and show that the Jagged2--Notch3 axis drives human γδ T cell development, at the expense of αβ-lineage differentiation.

RESULTS
=======

Notch ligands differentially affect TCR-αβ and TCR-γδ T cell development
------------------------------------------------------------------------

In both mouse and human, Notch signal strength can modulate the αβ/γδ T cell lineage choice ([@bib46]; [@bib7]; [@bib13]; [@bib37]; [@bib42]), but the mechanisms through which this is achieved are still unknown. Because we have recently shown that the Notch ligands *DLL4*, *JAG1*, and *JAG2* are expressed by human thymic epithelial cells (TECs) and that these ligands induce different levels of Notch1 signal strength ([@bib43]), we investigated their impact on human TCR-αβ and TCR-γδ T cell development. Human CD34^+^CD1a^−^CD4^−^ uncommitted postnatal thymocytes were driven into the CD7^+^CD1a^+^ T-lineage pathway upon culture onto OP9-DLL4, -JAG1, or -JAG2 and differentiated further into CD4^+^CD8β^+^ DP thymocytes ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, murine uncommitted c-Kit^+^ fetal thymocytes were blocked in T-lineage differentiation when cultured on OP9-JAG1 and failed to generate CD44^−^CD25^+^ double-negative 3 (DN3) or DP thymocytes in this condition compared with when cocultured on OP9-DLL4 or OP9-JAG2 ([Fig. 2](#fig2){ref-type="fig"}), illustrating the critical differences in Notch signaling requirements during mouse and human T cell development ([@bib35]; [@bib1]; [@bib39]). Human thymocytes revealed differences in T cell outcome, depending on to which Notch ligand the intrathymic progenitor cells were exposed. Phenotypic analysis revealed preferential differentiation into TCR-αβ T cells on OP9-JAG1, whereas DLL4 cultured cells developed into both αβ- and γδ-lineage cells ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, OP9-JAG2 cocultured cells differentiated mainly into TCR-γδ T cells ([Fig. 1 A](#fig1){ref-type="fig"}). The preferential αβ-lineage differentiation on OP9-JAG1 was seen early at day 6 by an increased number of CD4^+^CD8β^+^ DP thymocytes ([Fig. 1 C](#fig1){ref-type="fig"}) but finally did not result in higher αβ T cell numbers in these cultures ([Fig. 1 E](#fig1){ref-type="fig"}) as a result of lower total cell yields compared with OP9-DLL4 and OP9-JAG2 cocultures ([Fig. 1 B](#fig1){ref-type="fig"}). Although there was a slight increase in γδ T cell numbers on day 25 in OP9-JAG2 compared with OP9-DLL4 cocultures ([Fig. 1 D](#fig1){ref-type="fig"}), the most prominent difference between both was the strong reduction in TCR-αβ--lineage cells on OP9-JAG2 compared with -DLL4, as illustrated by the number of DP thymocytes ([Fig. 1 C](#fig1){ref-type="fig"}) and CD3^+^TCR-αβ^+^ T cells ([Fig. 1 E](#fig1){ref-type="fig"}). To explore the differential lineage outcome more robustly, clonal coculture experiments were initiated with CD34^+^CD1a^+^CD4^−^ committed T cell precursors (in contrast to the CD34^+^CD1a^−^CD4^−^ uncommitted used above), thereby avoiding any potential effects of differences in Notch ligands with respect to inducing T-lineage commitment. In addition, this is the human thymocyte population from which TCR-αβ and TCR-γδ T cells developmentally start to diverge ([@bib42]). [Fig. 1 F](#fig1){ref-type="fig"} shows the frequency of αβ-only, γδ-only, or bipotent αβ- and γδ-containing wells (left graph) or frequency of TCR-αβ-- or TCR-γδ--containing wells (right graph), but only within the repopulated wells. These data confirmed that DLL4 supports both TCR-αβ and TCR-γδ T cell differentiation, whereas Jagged1 almost exclusively supports αβ T cell development and Jagged2 mainly γδ T cell differentiation. When looking at the clonal outgrowth of all plated wells ([Fig. 1 G](#fig1){ref-type="fig"}), no difference in TCR-γδ output was observed in OP9-JAG2 cocultured cells compared with in OP9-DLL4 cocultures, but instead a significant reduction in TCR-αβ output was observed upon OP9-JAG2 coculture ([Fig. 1 G](#fig1){ref-type="fig"}), confirming the results from the bulk cocultures ([Fig. 1 E](#fig1){ref-type="fig"}).

![**Notch ligands differentially impact TCR-αβ versus TCR-γδ T cell development.** (A) Kinetic flow cytometric analysis of CD34^+^CD4^−^CD1a^−^ uncommitted intrathymic progenitors cultured for 11 or 18 d on OP9 cells expressing the different Notch ligands (DLL4, JAG1, or JAG2) as indicated above the dot plots. Numbers in the quadrants indicate the percentage of the corresponding populations. Dot plots shown are representative of three independent experiments. (B--E) Corresponding cell numbers of the kinetic flow cytometric analysis of cultures depicted in A. Graphs show the absolute number of all cells (B), CD4^+^CD8β^+^ DP cells (C), CD3^+^TCR-γδ^+^ (D), and CD3^+^TCR-αβ^+^ cells (E). Data shows the mean of three independent experiments and error bars show SEM. (F and G) Relative (F) or absolute (G) frequency of αβ-only, γδ-only, or bipotent αβ- and γδ-containing wells (left graphs) or frequency of TCR-αβ or TCR-γδ T cell--containing wells (right graphs) within single-plated CD34^+^CD4^--^CD1a^+^ T-lineage committed thymocytes on the different OP9 cell lines, as indicated in the graph, that showed T cell reconstitution after 20 d of coculture. Data shows the mean of three independent experiments and error bars show SEM.](JEM_20121798R_Fig1){#fig1}

![**Jagged1 fails to support DP differentiation from mouse thymocytes.** Flow cytometric data of murine c-kit^+^ fetal thymocytes after 7 or 10 d of coculture on OP9 stromal cells that express different Notch ligands (as indicated above dot plots). Early DN stages are distinguished by expression of CD44 and CD25 (top row) and T cell maturation is monitored by the coexpression of CD4 and CD8 (middle row). Development of TCR-γδ^+^CD3^+^ cells is shown in the bottom row. Results shown are representative of three independent experiments.](JEM_20121798_Fig2){#fig2}

Overall, these results show that Notch ligands critically influence human TCR-αβ and TCR-γδ T cell development. Although DLL4 supports both αβ- and γδ-lineage differentiation, Jagged1 predominantly supports TCR-αβ but not TCR-γδ development. In contrast, Jagged2 mainly supports γδ T cell differentiation at the expense of αβ T cells.

Jagged2 induces the strongest Notch signal in human thymocytes
--------------------------------------------------------------

Because our earlier studies had revealed that high Notch signal strength supports human TCR-γδ T cell development at the expense of TCR-αβ T cell development ([@bib8]; [@bib42]), the data in [Fig. 1](#fig1){ref-type="fig"} suggest that Jagged2 induces the strongest Notch signal in human postnatal thymocytes. To investigate this further, we reduced the Notch activation signal with different concentrations of γ-secretase inhibitor (GSI) in committed human CD34^+^CD1a^+^CD4^−^ thymocytes, as we have also shown that a decrease in Notch signaling activation enhances TCR-αβ T cell development ([@bib38]; [@bib42]). Consistent with the idea that Jagged2 induces the strongest Notch signal, TCR-αβ ([Fig. 3 A](#fig3){ref-type="fig"}) and CD4^+^CD8β^+^ ([Fig. 3 B](#fig3){ref-type="fig"}) differentiation could be restored in OP9-JAG2 cocultures at the expense of TCR-γδ T cell development ([Fig. 3 C](#fig3){ref-type="fig"}). Addition of low GSI concentrations also increased the frequencies of TCR-αβ^+^ and CD4^+^CD8β^+^ cells in Jagged1 and DLL4 cultured cells, but to a lesser extent. In agreement, although the number of TCR-αβ ([Fig. 3 D](#fig3){ref-type="fig"}) and CD4^+^CD8β^+^ ([Fig. 3 E](#fig3){ref-type="fig"}) thymocytes consistently and significantly increased upon addition of higher concentration of GSI (up to 1 µM) in OP9-JAG2 cocultures, such an increase in αβ-lineage cells was only observed with lower GSI concentration in OP9-DLL4 cocultures. In addition, the number of TCR-γδ T cells did not significantly decrease with the addition of 1 µM GSI in OP9-JAG2 cocultures, in contrast to OP9-DLL4 and OP9-JAG1 cocultures in which higher and significant reductions in γδ T cells were observed ([Fig. 3 F](#fig3){ref-type="fig"}). Also, gene expression analysis showed that Jagged2 is a stronger inducer of Notch signaling in human CD34^+^ thymocytes after 24-h exposure to equal amounts of coated Fc-tagged Notch ligands. The Notch target genes *HES1*, *DTX1*, *NRARP*, and *NOTCH3* were all up-regulated to a higher level in CD34^+^ thymocytes exposed to Jagged2 in comparison with DLL4 and much stronger compared with Jagged1 ([Fig. 3 G](#fig3){ref-type="fig"}). Thus, these results reveal that for human postnatal thymocytes, Jagged2 is the most potent ligand to induce Notch activation, thereby promoting TCR-γδ T cell development and blocking αβ-lineage differentiation.

![**GSI rescues Jagged2-mediated inhibition of αβ-lineage differentiation.** (A--C) Flow cytometric analysis of CD34^+^CD4^−^CD1a^+^ progenitors cultured during 19 d on OP9 cells expressing the different Notch ligands (DLL4, JAG1, or JAG2), as indicated above the dot plots, in the presence of different concentrations of GSI, as indicated on the right of the dot plots. Effects of GSI are shown on TCR-αβ^+^CD3^+^ T cells (A), CD4^+^CD8β^+^ DP thymocytes (B), and TCR-γδ^+^CD3^+^ T cells (C). Numbers in the quadrants indicate the percentage of the corresponding populations and data are representative of three independent experiments. (D--F) Absolute number of TCR-αβ^+^CD3^+^ T cells (D), CD4^+^CD8β^+^ DP thymocytes (E), and TCR-γδ^+^CD3^+^ T cells (F) of cultures shown in A--C. Triangles below graphs indicate an increasing dosage of GSI, corresponding to 0 µM, 0.2 µM, 0.5 µM, and 1 µM GSI. Data shows the mean from three independent experiments (errors bars indicate SEM, \* = P \< 0.05). (G) Quantitative RT-PCR analysis of human CD34^+^ thymic precursors after 24 h of culture on equal amounts of DLL4-Fc--, JAG1-Fc--, or JAG2-Fc--coated plates. Units of expression are given relative to GAPDH. Data shows the mean of two sets of independent samples (errors bars indicate SEM, \* = P \< 0.05).](JEM_20121798_Fig3){#fig3}

Notch ligands display preferential receptor binding
---------------------------------------------------

The idea that Jagged2 induces the strongest Notch signal in human postnatal thymocytes seemed to be in conflict with our recent findings with human HPCs in which Delta-like 4 induces the strongest signal through activation of Notch1 ([@bib43]). Therefore, we investigated whether different Notch receptors were expressed by both precursor subsets because different Notch ligand--receptor interactions could potentially explain this difference. Although Notch2 seemed an unlikely candidate based on its low but stable expression in human HSCs and throughout human T cell development ([@bib42]), both quantitative real-time PCR ([Fig. 4 A](#fig4){ref-type="fig"}) and protein expression through FACS analysis ([Fig. 4 B](#fig4){ref-type="fig"}) showed that, in addition to Notch2, cord blood (CB) CD34^+^ HSCs also express Notch1 but not Notch3, whereas thymocytes, already before T cell commitment at the CD34^+^CD1^−^ stage, express both Notch1 and Notch3, suggesting that differential Notch3 expression may account for the differences in Notch ligand responses between human HSCs and intrathymic progenitors. Indeed, binding studies ([Fig. 4 C](#fig4){ref-type="fig"}) revealed that Jagged2 can bind to Notch1 and also very efficiently to Notch3, whereas in contrast, DLL4 interacts with Notch1 but virtually not with Notch3. Jagged1 weakly binds to both Notch1 and Notch3. In addition, specific Notch receptor reporter assays ([Fig. 4 D](#fig4){ref-type="fig"}) confirmed that DLL4 is the most powerful ligand to activate Notch1-mediated signaling but also revealed that Jagged2 induced the strongest activation when signaling was mediated through Notch3.

![**Notch3 is expressed in uncommitted human thymocytes and is efficiently bound and activated by Jagged2.** (A) Quantitative RT-PCR analysis of Notch1 and Notch3 expression in freshly isolated human CB CD34^+^ cells and in different human thymocyte subsets. Units of expression are given relative to β-actin. Data shows the mean of two to eight sets of independent samples, and error bars indicate SEM. (B) Flow cytometric analysis of Notch1 and Notch3 receptor expression on freshly isolated CB or thymocytes. Density plots shown are representative of three independent experiments. Isotype staining was performed on total human thymocytes suspension. (C) Staining of control-Fc, Notch1-Fc, and Notch3-Fc fusion proteins to K562 cells expressing the different Notch ligands as indicated. Histograms shown are representative of three independent experiments. (D) Luciferase reporter assay of U2OS Tet-on flp-in-Notch1 and U2OS Tet-on flp-in-Notch3 cells cotransfected with CBF-luciferase reporter plasmid pGL2-Gal4-luciferase and the normalizing plasmid pRL-TK expressing Renilla luciferase. After plasmid transfection, cells were cocultured with K562 expressing *DLL4*, *JAG1*, *JAG2*, or control for 24 h, and thereafter luciferase activity was measured. Bar graphs show the mean of three independent experiments (error bars indicate SEM, \* = P \< 0.05).](JEM_20121798_Fig4){#fig4}

Together, these findings reveal that Jagged2 is a very potent Notch ligand for human thymocytes as a result of its interaction with both Notch1 and Notch3. In contrast, DLL4 only weakly binds and activates Notch3. Because a strong Notch signal favors γδ T cell development, this suggests an important role for Jagged2/Notch3 signaling during TCR-γδ T cell development.

Notch3 activation promotes γδ-lineage differentiation and inhibits TCR-αβ T cell development
--------------------------------------------------------------------------------------------

To functionally assess the influence of differential Notch receptor activation, we transduced uncommitted CD34^+^CD1a^−^ human intrathymic progenitors with the constitutive active forms of Notch1 and Notch3 (ICN1 and ICN3, respectively) and analyzed their impact on human αβ- and γδ-lineage differentiation. Consistent with previous findings ([@bib8]), ICN1 enhanced γδ T cell development and reduced differentiation into TCR-αβ^+^ and CD4^+^CD8β^+^ cells in a fetal thymus organ culture (FTOC) model system, both in terms of frequency and absolute cell number ([Fig. 5, A and B](#fig5){ref-type="fig"}). Importantly, ICN3 skewed differentiation toward the γδ-lineage choice in a similar manner but much more profoundly compared with ICN1. In addition, we performed coculture experiments on OP9 stromal cells that do not overexpress a human Notch ligand, to prevent activation of the endogenous Notch receptors that are present on human thymocytes. This prevents background differentiation of CD3^+^TCR-αβ^+^ or CD3^+^TCR-γδ^+^ thymocytes as illustrated with control transduced cells ([Fig. 5, C and D](#fig5){ref-type="fig"}). Under these conditions, ICN1 transduced precursors differentiate into both TCR-αβ^+^ and TCR-γδ^+^ T cells, whereas ICN3 transduced precursors only display γδ T cell potential ([Fig. 5, C and D](#fig5){ref-type="fig"}). Consistently, gene expression analysis revealed that ICN3 induces a stronger Notch signal compared with ICN1, as revealed by their influence on both positively (*HES1*, *DTX1*, and *NRARP*) and negatively (*TCR-Cα*) regulated genes ([Fig. 5 E](#fig5){ref-type="fig"}). This stronger induction of *HES1* and *DTX1* expression by ICN3 was confirmed in independent experiments with myc-tagged ICN-fusion proteins in which even lower amounts of ICN3 protein, compared with ICN1 as revealed through FACS-mediated myc staining, still induced much stronger expression of these Notch target genes (unpublished data). Thus, these findings illustrate that Notch3 activation results in a stronger downstream Notch signal compared with Notch1 activation and that Notch3 is a strong inhibitor of αβ T cell development.

![**Constitutive active Notch3 promotes γδ T cell development more profoundly and induces a stronger Notch signal compared with Notch1.** Control, ICN1, or ICN3 transduced CD34^+^CD4^−^CD1a^−^ thymocytes were submitted to FTOC (A and B) or cultured on OP9 stromal cells that were not transduced with any Notch ligand (C and D). Numbers in dot plots indicate the percentage of cells for the corresponding populations after 4 wk of FTOC (A) or 3 wk of OP9 coculture (C). Dot plots shown are representative for three to four independent experiments. Graphs show the mean absolute numbers of TCR-γδ^+^, TCR-αβ^+^, or CD4^+^CD8β^+^ DP thymocytes generated after 3 wk of FTOC (B) or 3 wk of OP9 coculture (D). Data are derived from four independent experiments (error bars indicate SEM). (E) Quantitative gene expression analysis of Notch and T cell--related genes in human thymus CD34^+^ cells, sorted for eGFP expression 2 d after transduction with ICN1, ICN3, or control virus. The expression levels are normalized to β-actin levels. Data shown are the mean of two to three sets of independent samples and error bars show SEM.](JEM_20121798R_Fig5){#fig5}

Notch3 activation is critical for promoting γδ T cell development
-----------------------------------------------------------------

To further show the functional importance of Notch3 activation in mediating human TCR-αβ and -γδ T cell development in the OP9 coculture system, we inhibited Notch3 activation using specific blocking antibodies ([@bib26]). Inhibition of Notch3 activation did not significantly alter T cell development in OP9-DLL4 and OP9-JAG1 cocultures but did significantly decrease the frequency of TCR-γδ^+^ T cells in OP9-JAG2 cocultures while increasing the frequency of TCR-αβ^+^ cells within the CD3^+^ fraction of thymocytes ([Fig. 6 A](#fig6){ref-type="fig"}). Although the number of γδ T cells only slightly decreased upon Notch3 inhibition in OP9-JAG2 cocultures ([Fig. 6 B](#fig6){ref-type="fig"}, P = 0.075), there was a significant increase in the number of TCR-αβ^+^ T cells in these cocultures when a Notch3 blocking antibody was added ([Fig. 6 C](#fig6){ref-type="fig"}).

![**Notch3 signaling is an important driver of human γδ T cell differentiation.** (A) Flow cytometric analysis of CD34^+^CD4^−^CD1a^−^ thymocytes after 4 wk of coculture on OP9 stromal cells that express the various Notch ligands and in the presence of control or blocking anti-Notch3 antibody, showing TCR-αβ and TCR-γδ staining of CD3^+^ gated thymocytes. Numbers in dot plots indicate the percentage of cells for the corresponding populations. (B) Absolute number of TCR-γδ T cells generated in cultures shown in A. (C) Absolute number of TCR-αβ T cells generated in cultures shown in A. Data are the mean from five independent experiments (errors bars indicate SEM, \* = P \< 0.05). (D) Flow cytometric analysis of CD34^+^CD4^−^CD1a^−^ thymocytes, transduced with control or full-length Notch1 (FLN1) or full-length Notch3 (FLN3), and cocultured for 3 wk on OP9 cells expressing the different Notch ligands (DLL4, Jagged1, or Jagged2) as indicated. Numbers in dot plots show the frequency of TCR-γδ T cells. Data are representative of three independent experiments. (E) Absolute number of TCR-γδ T cells generated from cultures shown in D. Data are derived from three independent experiments (errors bars indicate SEM, \* = P \< 0.05).](JEM_20121798_Fig6){#fig6}

Gene expression analysis had revealed that Jagged1 is not efficient at maintaining Notch3 expression in human CD34^+^ thymocytes ([Fig. 3 G](#fig3){ref-type="fig"} and not depicted). Because Jagged1 is capable of binding to ([Fig. 4 C](#fig4){ref-type="fig"}) and activating ([Fig. 4 D](#fig4){ref-type="fig"}) Notch3, this provided us with a model to test the functional importance of Notch3 activation for γδ-lineage differentiation because OP9-JAG1 cocultured human T cell progenitors predominantly differentiate into the TCR-αβ^+^ T cells. Therefore, we retrovirally transduced a full-length transmembrane Notch1 or Notch3 receptor into human CD34^+^CD1^−^ T-lineage precursors and cocultured these cells on the various OP9 stromal cells. In agreement with our previous data, increased Notch1 or Notch3 activation by DLL4 slightly increased the generation of γδ T cells ([Fig. 6, D and E](#fig6){ref-type="fig"}). More importantly, Notch3 expression was capable of significantly restoring γδ T cell development in human T cell progenitors in OP9-JAG1 cocultures ([Fig. 6, D and E](#fig6){ref-type="fig"}). In the case of OP9-JAG2 cocultures, increased Notch1 expression reduced the frequency ([Fig. 6 D](#fig6){ref-type="fig"}) but not the number ([Fig. 6 E](#fig6){ref-type="fig"}) of γδ T cells, whereas elevated Notch3 levels further increased γδ T cell differentiation ([Fig. 6, D and E](#fig6){ref-type="fig"}).

To further investigate the requirement for Jagged2 and Notch3 in human γδ T cell development in a more physiological setting, we performed hybrid human/mouse FTOC experiments in which human CD34^+^ thymocytes were used to reconstitute deoxyguanosine-treated fetal day 15 thymic lobes from gene-targeted JAG2^lox/lox^ mice that were crossed with knockin mice that express the *Cre recombinase* under the control of the *Foxn1* gene to induce specific JAG2 deletion in the TECs ([Fig. 7 A](#fig7){ref-type="fig"}). This resulted in a significant reduction in the number ([Fig. 7 B](#fig7){ref-type="fig"}) and frequency ([Fig. 7, C and D](#fig7){ref-type="fig"}) of human γδ T cells that developed in JAG2-deficient lobes compared with the control. Such a reduction in human γδ T cell development was not observed when JAG1-deficient fetal lobes were used (unpublished data). Flow cytometric analysis of Vδ1, Vδ2, Vδ3, and Vγ9 expression revealed no differences in the usage of these TCR V gene segments between γδ T cells generated in the presence or absence of Jagged2 ([Fig. 7 E](#fig7){ref-type="fig"}). Furthermore, the addition of blocking Notch3 antibodies to FTOC cultures, using deoxyguanosine-treated fetal lobes from wild-type mice, also resulted in a decrease in human γδ differentiation ([Fig. 7, F--H](#fig7){ref-type="fig"}). Overall, these findings clearly illustrate that Jagged2-mediated Notch3 activation is critical for human γδ T cell development.

![**Jagged2/Notch3 signaling is critical for human γδ-lineage differentiation.** (A) Flow cytometric analysis of Jagged2 expression in TECs from *Jag2*^lox/lox^*Foxn1-Cre^−/−^* (black histogram), *Jag2*^lox/wt^*Foxn1-Cre^+/−^* (white histogram), and *Jag2*^lox/lox^*Foxn1-Cre^+/−^* (gray histogram) fetal thymic lobes. Data are representative of three independent experiments. (B) Absolute number of human γδ T cells in FTOCs with *Jag2*^lox/lox^*Foxn1-Cre^−/−^* (black bar) and *Jag2*^lox/lox^*Foxn1-Cre^+/−^* (gray bar) fetal thymic lobes. Data shows the mean of seven independent experiments and error bars indicate the SEM (\* = P \< 0.05). (C) Mean frequency of human γδ T cells in FTOCs with *Jag2*^lox/lox^*Foxn1-Cre^−/−^* (black bar) and *Jag2*^lox/lox^*Foxn1-Cre^+/−^* (gray bar) fetal thymic lobes. Data show the mean of seven independent experiments and error bars indicate the SEM (\* = P \< 0.05). (D) Flow cytometric analysis of human T cell development in FTOCs with *Jag2*^lox/lox^*Foxn1-Cre^−/−^* and *Jag2*^lox/lox^*Foxn1-Cre^+/−^* fetal thymic lobes. Dot plots show CD3 versus TCR-αβ expression and histograms shown TCR-γδ expression in CD3^+^TCR-αβ^+^ (white histogram) versus CD3^+^TCR-αβ^−^ (black histogram) cells, gated from human CD45^+^ cells. Frequencies in dot plots show the frequency of γδ-lineage (CD3^+^TCR-αβ^−^TCR-γδ^+^) T cells. (E) Histograms show Vδ1, Vδ2, Vδ3, and Vγ9 staining from TCR-γδ gated cells shown in D. Numbers indicate the frequency of positive cells for the corresponding antigen. Data are representative of three independent experiments. (F) Absolute number of human γδ T cells in FTOCs with control (black bar) and blocking Notch3 antibodies (gray bar). Data shows the mean of three independent experiments and error bars indicate the SEM. (G) Mean frequency of human γδ T cells in FTOCs with control (black bar) and blocking Notch3 antibodies (gray bar). (H) Flow cytometric analysis of human T cell development in FTOCs with control or blocking Notch3 antibodies. Dot plots show CD3 versus TCR-αβ expression and histograms shown TCR-γδ expression in CD3^+^TCR-αβ^+^ (white histogram) versus CD3^+^TCR-αβ^−^ (black histogram) cells, gated from human CD45^+^ cells. Frequencies in dot plots show the frequency of γδ-lineage (CD3^+^TCR-αβ^−^TCR-γδ^+^) T cells. Data are representative for three independent experiments.](JEM_20121798_Fig7){#fig7}

TCR transgenes overcome ligand-induced TCR choices
--------------------------------------------------

The observed differences in TCR-αβ and TCR-γδ T cell development by the different Notch ligand--receptor interactions could be the result of preferential outgrowth of cells with a particular TCR in those culture conditions rather than a developmental choice on its own. To gain additional insights, we analyzed intracellular TCR-β (icTCR-β) chain expression in developing human T-lineage progenitors exposed to the different Notch ligands, as this is a key early event that distinguishes most of the developing αβ-lineage progenitors from those differentiating along the γδ T cell pathway. Although virtually all cocultured cells belonged to the T cell lineage as shown by intracellular expression of CD3ε ([Fig. 8 A](#fig8){ref-type="fig"}), Jagged1-exposed thymocytes contained the highest frequency of icTCR-β^+^ cells---slightly higher compared with DLL4 but significantly higher compared with thymocytes cocultured on OP9-JAG2, which displayed a low frequency of icTCR-β^+^ cells ([Fig. 8, A and B](#fig8){ref-type="fig"}). To explore the functional importance of this reduced TCR-β chain expression upon OP9-JAG2 coculture, human CD34^+^CD4^−^CD1a^−^ postnatal thymocytes were transduced with a retrovirus encoding a functional TCR-β or TCR-δ chain before coculture of the cells on the different OP9 stromal cells. Strikingly, Notch ligands had virtually no differential impact on the outgrowth of thymocytes with a functional, rearranged TCR. Progenitors transduced with a TCR-β chain developed into TCR-αβ^+^ CD3^+^ T cells and CD4^+^CD8β^+^ thymocytes on all three Notch ligands ([Fig. 8, C and D](#fig8){ref-type="fig"}), even on Jagged2, and with similar efficiencies compared with DLL4 with respect to the absolute number of αβ-lineage cells generated ([Fig. 8, F and G](#fig8){ref-type="fig"}). In contrast, OP9 cocultures initiated with TCR-δ transduced thymocytes yielded TCR-γδ^+^ CD3^+^ T cells on all three Notch ligands ([Fig. 8, E and H](#fig8){ref-type="fig"}) and reduced TCR-αβ T cell differentiation ([Fig. 8 F](#fig8){ref-type="fig"}). Even when cocultured on Jagged1, precursors can develop into TCR-γδ^+^ T cells when a functional TCR-δ is provided ([Fig. 8 E](#fig8){ref-type="fig"}), although with reduced efficiency ([Fig. 8 H](#fig8){ref-type="fig"}).

![**Jagged2-mediated inhibition of TCR-β chain expression represses αβ-lineage differentiation.** (A) Flow cytometric analysis of intracellular CD3ε and TCR-β expression in CD34^+^CD4^−^CD1a^−^ thymic progenitors after 3 wk of coculture on OP9 stromal cells expressing the different Notch ligands. Data are representative of three independent experiments. (B) The mean frequency of icTCR-β^+^ cells generated from CD34^+^CD4^−^CD1a^−^ thymic progenitors on the various OP9 stromal cells. Data are derived from three independent experiments (error bars indicate SEM, \* = P \< 0.05). (C--E) Flow cytometric analysis of human CD34^+^CD4^--^CD1a^--^ thymic progenitors transduced with control, TCR-β, or TCR-δ after coculture on OP9 stromal cells expressing the different human Notch ligands, as indicated above the dot plots. Numbers in top right quadrants indicate the percentage of TCR-αβ^+^CD3^+^ cells (C), CD4^+^CD8β^+^ DP cells (D), or TCR-γδ^+^CD3^+^ cells (E). (F--H) Bar diagrams show the absolute numbers of TCR-αβ^+^CD3^+^ cells (F), CD4^+^CD8β^+^ DP cells (G), or TCR-αβ^+^CD3^+^ cells (H) obtained after OP9 coculture with the different Notch ligands. Error bars represent means and SEM of three independent experiments (D4 = DLL4, J1 = JAG1, and J2 = JAG2).](JEM_20121798_Fig8){#fig8}

Thus, the introduction of a functional TCR transgene into thymic precursors overcomes the ligand-induced lineage outgrowth that is observed with unmanipulated thymocytes. These results therefore indicate that Notch ligand--receptor interactions do not affect the outgrowth of T cell progenitors that express a specific TCR, but that instead they influence the developmental pathway of early T cell precursors into either TCR-αβ-- or TCR-γδ--expressing T cells.

DISCUSSION
==========

During intrathymic T cell development, differentiating T cell progenitors migrate to different regions within the thymus that provide stage-specific environmental queues that drive their further differentiation ([@bib29]). One of the most important signaling cascades during early T cell development comprises the Notch signaling pathway and it is well established that the αβ versus γδ T cell lineage choice is modulated by differential Notch signal strength in both mouse and human ([@bib35]; [@bib6]; [@bib25]; [@bib39]). However, it has remained unclear which receptor--ligand interactions are involved in these processes and, moreover, the Notch dependency for TCR-αβ and TCR-γδ T cell development was shown to be different between both species ([@bib46]; [@bib8]; [@bib14]; [@bib7]; [@bib13]; [@bib37]; [@bib42]). Here, we demonstrate that differential Notch receptor--ligand interactions control human TCR-αβ and TCR-γδ T cell development by inducing different Notch signal strengths and show that the Jagged2--Notch3 interaction is critical for human γδ T cell development. Importantly, our data provide a mechanistic insight into the high Notch dependency for developing human γδ T cells.

In the mouse, it is well established that Notch1-DLL4 signaling is essential for inducing T cell differentiation in the immigrating T cell precursors ([@bib47]; [@bib19]; [@bib23]) and we believe that this interaction is also involved in inducing early T cell development in human. From our previous work, it is clear that Notch1 activation is responsible for inducing human T cell development ([@bib42], [@bib43]), and although it remains to be clarified whether Delta-like 4 or Jagged2 is responsible for activating this receptor, the notion that a strong Notch signal is critical at this early stage of human T cell development ([@bib42]) makes Delta-like 4 the most likely ligand ([@bib43]). More importantly, Notch1 activation at this early stage of T cell development induces high Notch3 expression, as also illustrated previously ([@bib42], [@bib43]), making this newly expressed receptor accessible for ligand-mediated Notch activation within the thymus.

In both mouse and human, Notch signal strength modulates TCR-αβ and TCR-γδ T cell development ([@bib46]; [@bib8]; [@bib14]; [@bib7]; [@bib13]; [@bib37]; [@bib42]), a process which, in vivo, occurs in the cortex ([@bib29]). We have recently shown that JAG2 is expressed by the majority of human cortical TECs, in addition to DLL4 which is less abundantly expressed in this region ([@bib43]), indicating that both ligands can mediate the development of both T cell subsets. Consistent with the notion that human γδ T cells preferentially develop in the presence of high Notch activation ([@bib8]; [@bib14]; [@bib42]), we show here that Jagged2 preferentially induces human γδ T cell differentiation by inducing the strongest Notch signal in immature thymocytes through interactions with both Notch1 and Notch3, in contrast to Delta-like 4 which predominantly interacts with Notch1 and supports both αβ- and γδ-lineage differentiation. In addition, Jagged2 is the most potent Notch ligand to activate signaling through the Notch3 receptor, which in term is a stronger inducer of Notch activation compared with Notch1 as illustrated by the stronger induction or repression of Notch target genes. This additional efficient interaction of Jagged2 with Notch3 explains why the Notch signal strength hierarchy for the different human Notch ligands is different for thymocytes compared with for HPCs that only express Notch1 and Notch2 ([@bib42]), conditions in which DLL4 induces the strongest Notch ligand ([@bib43]). This indicates that the induction of Notch signal strength in signal-receiving cells is highly dependent on its own repertoire of Notch receptors and on the combination of ligands expressed by the signal-sending cell. Because thymocytes migrate through the cortex during their development, our results propose that competition between Notch ligands for engagement of Notch1 and Notch3 will determine the T cell lineage outcome. Despite the abundance of Jagged2 in the human cortex, we anticipate that the strong interaction between DLL4 and Notch1, which results in a strong Notch1 activation, prevents a predominant induction of human γδ T cell development.

Recently, we have shown that Jagged1 does not induce a sufficient strong Notch signal in extrathymic human and mouse HPCs to induce T cell development in contrast to Jagged2, DLL1, and DLL4 ([@bib43]). Here, we demonstrate that the weak Notch signal that is induced by Jagged1 is capable of generating DP and TCR-αβ^+^CD3^+^ thymocytes from uncommitted postnatal thymocytes from human---in agreement with previous observations ([@bib11]; [@bib42])---but not from mouse. Consistently, we show that Jagged1 does not support γδ T cell development in human, whereas this ligand is sufficient for murine TCR-γδ T cell differentiation, illustrating the opposing Notch signaling requirements between mouse and human ([@bib35]; [@bib39]). This difference corresponds with a differential Notch activation status during intrathymic T cell development between mouse and human as illustrated by the expression levels of Notch target genes in both species. In humans, it is clear that the strongest Notch signals are delivered in uncommitted CD34^+^CD1^−^ thymocytes as they express the highest levels of *DTX1* and *NRARP*, genes which are highly sensitive to changes in Notch activation ([@bib42]). In contrast, Notch target genes peak at the DN3 stage of mouse T cell development when T cell commitment is completed ([@bib37]; [@bib41]; [@bib50]), a clear difference compared with human ([@bib42]). Also *NOTCH3*, whose expression is induced upon Notch1 signaling, is expressed earlier during human compared with during mouse T cell development. Because our results show that Jagged1 is incapable of activating these target genes (*DTX1*, *NRARP*, and *NOTCH3*), human postnatal thymocytes can further differentiate along the αβ-lineage, as up-regulation of these genes is apparently no longer needed for further differentiation along that pathway. Because human thymocytes continue to express *NOTCH3* after the induction of T-lineage commitment, it is unlikely that Jagged1 is involved in vivo in these early stages of human αβ-lineage differentiation. Mouse thymocytes, however, fail to generate DP αβ-lineage cells in OP9-JAG1 cocultures, presumably because these Notch target genes need to be further up-regulated upon T-lineage commitment to reach their peak at the DN3 stage ([@bib37]). The inability of Jagged1 to induce *DTX1*, *NRARP*, and *NOTCH3* was also evident in human CB-derived HSCs and might explain why Jagged1 was not sufficient to induce T-lineage specification in human HPCs ([@bib43]). Further studies will need to clarify which Notch target genes are essential for initiating the T-lineage differentiation program.

Importantly, the early up-regulation of Notch3 during human T cell development in comparison with the mouse might explain the difference in Notch dependency of TCR-αβ and TCR-γδ T cell differentiation that is observed between both species ([@bib46]; [@bib7]; [@bib13]; [@bib37]; [@bib42]). In humans, both types of T cells start to diverge at the CD34^+^CD1^+^ stage when Notch3 is already highly expressed ([@bib42]), allowing Notch3 to influence this lineage choice through activation of Jagged2 that is abundantly expressed by human TECs ([@bib43]). In contrast, Notch3 expression in the mouse peaks at the DN3 stage ([@bib37]; [@bib33]), after the onset of αβ versus γδ T lineage bifurcation ([@bib7]). Although there is clear detectable Notch3 expression at the DN2 stage when αβ and γδ T cells start to diverge ([@bib33]), it is unclear if these levels are sufficient to mediate these developmental processes, especially because recent data revealed no obvious defect in mouse γδ T cell development in the absence of Notch3 ([@bib33]; [@bib34]). In addition, it is unclear how much Jagged2 protein is expressed by the TECs of the mouse, and in situ RNA expression analysis suggests that DLL4 is more abundantly expressed in the mouse cortex compared with Jagged2 ([@bib18]), raising the possibility that Notch3 might not be sufficiently activated to mediate this early developmental T cell choice. Nevertheless, the observation that Jagged2-deficient mice display a reduction in fetal γδ T cell development is consistent with our human findings ([@bib20]).

The block in TCR-γδ T cell differentiation was not complete upon Notch3 inhibition or in the absence of Jagged2, which is consistent with the observation that Notch1 activation can also induce γδ T cell development. However, from the FTOC experiments it is obvious that at least part of human γδ T cells require Jagged2-mediated Notch3 activation for their development. Given our observation that the generation of a TCR-β chain is impaired in Jagged2 cocultured thymocytes and because introduction of a functional TCR-β chain fully restores αβ T cell development under these conditions, it is clear that the failure of TCR-β chain production is causing the inhibition of TCR-αβ differentiation that is induced upon Jagged2/Notch3 signaling, thereby favoring the development of γδ T cells. Given that Notch3 continues to be expressed in DP thymocytes that are the immediate precursors of αβ T cells, we speculate that Notch3 might also be important for allelic exclusion and prevention of further TCR-β chain rearrangements when the rearrangement machinery is again activated to induce TCR-α rearrangements. Interestingly, the generation of a functional TCR-β chain has been shown to be dependent on Notch1 signaling in the mouse ([@bib48]) and presumably also in humans ([@bib9]). Although our gene expression analysis only reveals quantitative and no qualitative differences between Notch1 and Notch3 in their potential to activate or repress Notch target genes, previous work has proposed that Notch3 can inhibit Notch1 function ([@bib3]), leaving the possibility that TCR-β chain rearrangements are differentially affected by Notch1 and Notch3. Although currently impossible because of the lack of specific ICN3 reagents, genome-wide ChIP studies will help to clarify whether Notch1 and Notch3 target the same genes or not.

Overall, our results reveal a critical role for Notch receptor--ligand interactions in the development of T cells bearing either a γδ or αβ TCR and, as such, propose a novel role for Notch signaling in the generation of these TCRs, possibly by affecting TCR rearrangements. Although the expression of such a γδ or αβ TCR does not necessarily correspond with their further differentiation along the DN γδ- or DP αβ-lineages, respectively, we did observe a correlation between TCR-αβ T cell development and the generation of CD4^+^CD8β^+^ DP thymocytes in our cultures. Such a correlation between the TCR and the corresponding lineage differentiation program is also observed in the majority of αβ- and γδ-lineage T cells in wild-type mice, but it was also clearly demonstrated that the strength of signal through the TCR is critical in establishing the αβ- versus γδ-lineage choice ([@bib16]; [@bib17]), with Notch signal strength presumably playing a modulatory role ([@bib12]). Such elegant genetic studies are difficult to achieve in humans but now become feasible using gene-modified human ES cells that can differentiate along the T cell pathway in vitro ([@bib40]). These studies will be required to define the precise contributions of TCR and Notch signal strengths in mediating the αβ- versus γδ-lineage choice in human. Nevertheless, based on the current evidence from in vitro studies using mouse and human ex vivo--isolated progenitors, it is clear that the requirements for Notch signaling during the early stages of T cell development are distinct between both species ([@bib39]). The results in this manuscript indicate that this may occur at the level of TCR generation.

MATERIALS AND METHODS
=====================

### Isolation of thymocytes and retroviral transduction.

Pediatric thymus samples were obtained and used according to the guidelines of the Medical Ethical Commission of Ghent University Hospital (Belgium). CD34^+^ thymocytes were enriched using CD34 magnetic-activated cell-sorting (MACS; Miltenyi Biotec), according to the manufacturer's instructions. Enriched CD34^+^ thymocytes were labeled with CD34-APC, CD4-PE, and CD1-FITC to sort (FACSAria II; BD) CD34^+^CD4^−^CD1a^−^ and CD34^+^CD4^−^CD1a^+^ fractions. Isolation of other thymocyte subsets has been described previously ([@bib38]; [@bib42]). Purity of the sorted cells was checked on a FACSCalibur (BD) and was always \>98%. cDNA encoding constitutively active or full-length Notch3 was subcloned from previously described constructs ([@bib45]) into the multicloning site of the retroviral vector MSCV-EGFP. Generation of the plasmid containing ICN1 has been described previously ([@bib8]) and the MSCV construct encoding full length Notch1 was provided by W. Pear (University of Pennsylvania, Philadelphia, PA). Viruses encoding functional TCR transgenes were LZRS-IRES-TCRβ-EGFP (TCRβ; [@bib38]) and LZRS-IRES-TCRδ-EGFP (TCRδ, provided by D. Vermijlen, ULB, Gosselies, Belgium; [@bib44]). Retroviral transduction of thymocytes has been described ([@bib38]).

### OP9 cocultures.

Purified progenitors were seeded onto plates (24-well or 96-well) confluent with OP9-DLL4, OP9-JAG1, or OP9-JAG2 cells and these cells have been previously well described to express similar levels of each Notch ligand ([@bib43]; [@bib21]). OP9 cocultures were all performed in α-MEM media (Invitrogen) supplemented with 20% heat-inactivated FCS (Hyclone) plus 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM [l]{.smallcaps}-glutamine (all from Invitrogen). CD34^+^CD4^−^CD1^−^ or CD34^+^CD4^−^CD1^+^ cells were cultured in the presence of 5 ng/ml IL-7, 5 ng/ml Flt-3L, and 5 ng/ml SCF. For OP9 cocultures started with retrovirally transduced CD34^+^CD4^−^CD1^−^ or CD34^+^CD4^−^CD1^+^ progenitors, EGFP^+^ transduced cells were first sorted and subsequently subjected to coculture. For γ-secretase inhibition (GSI) experiments, different concentrations of DAPT (0 µM--0.2 µM--0.5 µM--1 µM) were added to the cocultures and an equal concentration of DMSO (0 µM GSI) was added as control. Notch3 blocking experiments were performed by adding 1 or 5 µg/ml of the G3 isotype control or A4 anti-Notch3 antibody (provided by C. Siebel, Genentech, San Francisco, CA; [@bib26]). Every 2--3 d, half of the medium was refreshed to maintain antibody concentrations. Cocultures were harvested by forceful pipetting at the indicated time points.

### FTOC

FTOCs with control, ICN1, or ICN3 transduced cells were performed as described previously ([@bib36]). NOD-LtSz-scid/scid (NOD-SCID) mice (originally purchased from The Jackson Laboratory) were obtained from our own specific pathogen-free breeding facility. To perform FTOCs with JAG1- and JAG2-deficient fetal thymic lobes, homozygous *Jag1*^lox/lox^ mice ([@bib28]) or *Jag2*^lox/lox^ mice ([@bib49]) were crossed to *Foxn1-Cre* mice (gift from N. Manley, University of Georgia, Athens, GA; [@bib15]) to generate *Jag1*^lox/wt^*Foxn1-Cre^+/−^* and *Jag2*^lox/wt^*Foxn1-Cre^+/−^* mice, respectively. These animals were subsequently intercrossed to obtain *Jag1*^lox/lox^*Foxn1-Cre^+/−^* and *Jag1*^lox/lox^*Foxn1-Cre^−/−^* mice, and *Jag2*^lox/lox^*Foxn1-Cre^+/−^* and *Jag2*^lox/lox^*Foxn1-Cre^−/−^* mice. Fetuses from these intercrossings were isolated at fetal day 15--15.5 of gestation and fetal thymic lobes were treated for 5 d with 1.35 mM 2′-deoxyguanosine to remove all endogenous mouse thymocytes. Subsequently, between 5,000 and 10,000 human progenitor cells were added to each lobe in 2-d hanging drop cultures, before further culture as described above for FTOCs. Fetal liver from the same fetus was used to genotype the animals. All mice were treated according to the guidelines of the Laboratory Animal Ethical commission of the University Hospital of Ghent.

### Monoclonal antibodies and flow cytometry.

Cell suspensions obtained from cocultures were first blocked with anti--mouse FcRγII/III (clone 2.4.G2) and human IgG (Fcblock; Miltenyi Biotec) to avoid nonspecific binding. Cell suspensions obtained after FTOCs were also blocked with anti--mouse FcRγII/III mAb and stained with rat anti--mouse monoclonal antibody CD45-cychrome to gate out mouse cells during flow cytometry. Subsequently, cells were stained with combinations of anti--human monoclonal antibodies as indicated and as described previously ([@bib38]; [@bib42]). OP9 cocultures were always gated on human CD45^+^ cells. Cells were examined for the expression of cell surface markers on an LSRII (BD) and human viable cells were gated by excluding propidium iodide--positive cells from analysis.

### Reverse transcription PCR.

For gene expression analysis, CD34^+^ thymocytes were cultured for 24 h in tissue culture plates that were precoated with Fc-tagged Notch ligands as previously described ([@bib43]). In the case of ICN1, ICN3, and MSCV transduced cells, cells were harvested and EGFP^+^ cells were sorted. Cells were resuspended in RLT buffer and stored at −70°C before RNA isolation. RNA was extracted using RNeasy RNA isolation kit (QIAGEN) and converted into cDNA using Superscript RT II (Invitrogen).

Real-time PCR reactions were performed using the qPCR Core kit for SYBR Green I (Eurogentec) on a 7300 Real-time PCR system (Applied Biosystems). Relative expression levels were calculated for each gene using the ΔΔCt method using GAPDH or β-actin for normalization.

### Luciferase reporter assay and binding studies.

Luciferase reporter assays were performed as previously described ([@bib43]). In brief, U2OS Tet-on flp-in cells bearing isogenic transgenes encoding Notch1-Gal4 or Notch3-Gal4 chimeric receptors (gift from J. Aster, Harvard University, Boston, MA; [@bib26]) were transfected with Gal4-firefly luciferase and pRL-TK Renilla reporter plasmid. After 1 d, K562 cells expressing Notch ligands were added together with 2 µg/ml tetracycline. 1 d later, luciferase activity was measured in cell lysates using a dual luciferase reporter system (Promega).

Binding studies were performed using K562 cells retrovirally transduced with the different Notch ligands (Delta-like 4, Jagged1, and Jagged2) or the empty vector LZRS-EGFP as a control ([@bib43]). The K562 cells were washed in complete IMDM and aliquoted at 2 × 10^5^ cells in 100 µl of binding buffer (HBSS containing 1 mM CaCl~2~, 1% BSA, and 0.05% NaN~3~). The cells were incubated with the Fc-tagged Notch receptors (R&D Systems) or human IgG1 isotype control (Enzo Life Sciences) at 4°C for 40 min. After washing two times with binding buffer, the cells were incubated with a PE-conjugated anti--human Fc (eBioscience).
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